Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising Natural Killer T Cell-based Therapy
- PMID: 36638561
- PMCID: PMC10037488
- DOI: 10.1164/rccm.202211-2134LE
Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising Natural Killer T Cell-based Therapy
Comment in
-
Reply to Wang and Zhou.Am J Respir Crit Care Med. 2023 Mar 15;207(6):796-798. doi: 10.1164/rccm.202212-2214LE. Am J Respir Crit Care Med. 2023. PMID: 36638560 Free PMC article. No abstract available.
Comment on
-
Impairment of the NKT-STAT1-CXCL9 Axis Contributes to Vessel Fibrosis in Pulmonary Hypertension Caused by Lung Fibrosis.Am J Respir Crit Care Med. 2022 Oct 15;206(8):981-998. doi: 10.1164/rccm.202201-0142OC. Am J Respir Crit Care Med. 2022. PMID: 35763380
References
-
- Jandl K, Marsh LM, Mutgan AC, Crnkovic S, Valzano F, Zabini D, et al. Impairment of the NKT-STAT1-CXCL9 axis contributes to vessel fibrosis in pulmonary hypertension caused by lung fibrosis. Am J Respir Crit Care Med . 2022;206:981–998. - PubMed
-
- Romero-Olmedo AJ, Schulz AR, Huber M, Brehm CU, Chang HD, Chiarolla CM, et al. Deep phenotypical characterization of human CD3+ CD56+ T cells by mass cytometry. Eur J Immunol . 2021;51:672–681. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
